1. Volume 13, Issue 7, Pages 666-675 (July 2014)
Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial 
Peter J Kirkpatrick, FMedSci, Carole L Turner, MSc, Christopher Smith, PhD, Prof Peter J Hutchinson, FRCS, Prof Gordon D Murray, PhD 
The Lancet Neurology 
Volume 13, Issue 7, Pages (July 2014)
DOI: /S (14)
Copyright © 2014 Elsevier Ltd Terms and Conditions

2. Figure 1
Trial profile
DSA=digital subtraction angiography. A screening log is a document that records all patients who enter the screening process before consent.
The Lancet Neurology  , DOI: ( /S (14) )
Copyright © 2014 Elsevier Ltd Terms and Conditions

3. Figure 2 Distribution of scores on the mRS scale
(A) At 6 months. (B) At discharge. mRS=modified Rankin Scale.
The Lancet Neurology  , DOI: ( /S (14) )
Copyright © 2014 Elsevier Ltd Terms and Conditions

4. Figure 3 Kaplan-Meier survival curve
The Lancet Neurology  , DOI: ( /S (14) )
Copyright © 2014 Elsevier Ltd Terms and Conditions

5. Figure 4
Distribution of scores on the mRS scale at 6 months for patients who were fully compliant to study medication
The Lancet Neurology  , DOI: ( /S (14) )
Copyright © 2014 Elsevier Ltd Terms and Conditions

6. Figure 5
Influence of key pre-randomisation characteristics of patients and treatment type on favourable or unfavourable outcome, post-hoc analysis
WFNS=World Federation of Neurosurgical Societies.
The Lancet Neurology  , DOI: ( /S (14) )
Copyright © 2014 Elsevier Ltd Terms and Conditions

7. Figure 6 Randomised trials measuring neurological outcome at discharge
The Lancet Neurology  , DOI: ( /S (14) )
Copyright © 2014 Elsevier Ltd Terms and Conditions